US$ 23.74
aod9604 human studies AOD 9604 5mg AOD-9604 (5MG)
Description
AOD-9604 Supplies Needed Plan based on subcutaneous research dosing of 300-500 mcg/day from a 5 mg vial reconstituted with 3.0 mL bacteriostatic water

Many patients may report an increase in energy and a decrease in fatigue after starting B-complex injections, usually within days to a couple of weeks of regular treatment

Cox HD, et al

Highly recommended. Dulce R

What dose of AOD-9604 do scientists use in animal models

AOD 9604 was actually developed far enough to go through human clinical trials for obesity treatment
